<unk> , sold under the brand name ExEm Foam, is a drug for the detection of fallopian tube patency (openness) in women with known or suspected infertility. It was approved for use in the United States in November 2019.<unk>  is infused into the uterus to allow for visual assessment of fallopian tubes during an ultrasound examination called a sonohysterosalpingography. The most common adverse reactions are pelvic pain and abdominal pain, nausea and faintness (caused by a nerve and blood vessel reaction called vasovagal reaction) and post-procedure spotting.
Air polymer-type A
Eagle III
Highmark
Large cell
Microporous material
B type inclusion
Complex of Sultan Bayezid II
Titratable acid